|
Beta Drugs Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
1658.43 Cr.
|
P/BV
|
9.17
|
Book Value (Rs.)
|
179.17
|
|
52 Week High/Low (Rs.)
|
2170/1429
|
FV/ML
|
10/1
|
P/E(X)
|
39.10
|
|
Bookclosure
|
26/03/2025
|
EPS (Rs.)
|
42.02
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 362.36 | 295.71 | 227.11 | 183.84 | 116.12 |
| Total Operating Revenues | 362.36 | 295.71 | 227.11 | 183.84 | 116.12 |
| | | | | | |
| Other Income | 6.44 | 1.36 | 0.75 | 0.76 | 0.50 |
| Total Revenue | 368.79 | 297.07 | 227.87 | 184.59 | 116.62 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 175.78 | 167.65 | 110.40 | 96.21 | 60.55 |
| Operating And Direct Expenses | 40.62 | 31.79 | 24.29 | 17.78 | 13.40 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -4.42 | -18.24 | -4.71 | -1.75 | -1.77 |
| Employee Benefit Expenses | 33.92 | 25.89 | 22.70 | 15.91 | 10.88 |
| Finance Costs | 6.99 | 2.82 | 2.41 | 1.90 | 2.42 |
| Depreciation And Amortisation Expenses | 12.51 | 9.78 | 10.41 | 7.25 | 6.87 |
| Other Expenses | 41.86 | 28.63 | 21.31 | 12.99 | 8.31 |
| Total Expenses | 307.25 | 248.32 | 186.81 | 150.29 | 100.67 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 61.54 | 48.75 | 41.06 | 34.30 | 15.95 |
| | | | | | |
| Exceptional Items | -4.57 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 56.97 | 48.75 | 41.06 | 34.30 | 15.95 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 14.97 | 12.53 | 10.86 | 9.51 | 4.71 |
| Deferred Tax | -0.42 | -0.21 | -0.52 | -0.03 | -0.48 |
| Total Tax Expenses | 14.55 | 12.32 | 10.34 | 9.47 | 4.23 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 42.42 | 36.44 | 30.72 | 24.83 | 11.72 |
| | | | | | |
| Profit/Loss From Continuing Operations | 42.42 | 36.44 | 30.72 | 24.83 | 11.72 |
| | | | | | |
| Profit/Loss For The Period | 42.42 | 36.44 | 30.72 | 24.83 | 11.72 |
| Consolidated Profit/Loss After MI And Associates | 42.42 | 36.44 | 30.72 | 24.83 | 11.72 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 42.02 | 37.90 | 31.95 | 25.82 | 12.20 |
| Diluted EPS (Rs.) | 42.02 | 37.90 | 31.95 | 25.82 | 12.20 |
